Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours.

Conclusion: EGFR plays a role in transmembrane signal transduction. The Nbs, especially anti-EGFR-Nbs have shown effectiveness in the diagnosis and treatment of solid tumours. How to increase the affinity of Nb and reduce its immunogenicity remains a great challenges. PMID: 32885759 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32885759?dopt=Abstract

Source: Recent Patents on Anti-Cancer Drug Discovery - September 6, 2020 Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research